HSIC vs DBVT vs ALKS vs DXPE

For growth investors, DXP Enterprises, Inc.

(DXPE) is the stronger pick with 11. 9% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 7x versus DXP Enterprises, Inc. at 29. 1x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x.

Over the past 5 years, DXP Enterprises, Inc.

(DXPE) delivered a total return of +389. 0%, compared to -68. 3% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: DXPE returned +732. 1% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 72β versus DXP Enterprises, Inc. 's 1. 70β — meaning DXPE is approximately 134% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 197% for DXP Enterprises, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), DXP Enterprises, Inc.

(DXPE) is pulling ahead at 11. 9% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: DXP Enterprises, Inc. grew EPS 27. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, DXPE leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Henry Schein, Inc.

(HSIC) trades at 13. 2x forward P/E versus 25. 5x for DXP Enterprises, Inc. — 12. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 134. 8% to $46. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Henry Schein, Inc.

(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). Both have compounded well over 10 years (HSIC: +5. 8%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HSIC (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and DXPE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.